US Patent

US10695303 — Topical compositions and methods for making and using same

Formulation · Assigned to Sebela Ireland Ltd · Expires 2033-01-31 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects improved topical gel compositions containing an active agent and methods for making and using them.

USPTO Abstract

The present invention relates to improved topical gel compositions comprising an active agent, and uses thereof.

Drugs covered by this patent

naftifine-hydrochloride (NAFTIFINE HYDROCHLORIDE)

Patent Metadata

Patent number: US10695303
Jurisdiction: US
Classification: Formulation
Expires: 2033-01-31
Drug substance claim: No
Drug product claim: Yes
Assignee: Sebela Ireland Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.